Clinical Trial Update: A Study to Evaluate the Long-Term Safety and Efficacy of Bimekizumab in Subjects With Psoriatic Arthritis [Phase 2]

View source ↗

Summary

Phase 2 trial assessing long-term safety and efficacy of bimekizumab in psoriatic arthritis has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psoriatic Arthritis

Drugs mentioned

• Bimekizumab (bimekizumab)

Snippet

Sponsor: UCB Biopharma SRL | Conditions: Psoriatic Arthritis | Phase 2 | Status: COMPLETED | Results posted: 2023-12-01